Fingerprint
Dive into the research topics of 'Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study
Holland C. Detke, Peter J. Goadsby, Shufang Wang, Deborah I. Friedman, Katherine J. Selzler, Sheena K. Aurora
Research output: Contribution to journal › Article › peer-review
396
Scopus
citations